| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.003 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.003 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.089 | 0.005 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.083 | 0.006 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.093 | 0.007 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |